Skip to main content
HR 4769 109th Congress House Health Accreditation (Medical care) Administrative procedure Business records Commerce Communication in medicine Congress Congressional reporting requirements Consumer education Crime and Law Enforcement Data banks Death Department of Health and Human Services Drug abuse Drug addiction Drug industry Drug law enforcement Drugs Economics and Public Finance Electronic commerce

Prescription Drug Abuse Elimination Act of 2006

Introduced: February 16, 2006 See on congress.gov
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 17, 2006
Referred to the Subcommittee on Health.
Feb 16, 2006
Referred to the House Committee on Energy and Commerce.
Feb 16, 2006
Introduced in House
 Plain-English summary Congressional Research Service

Prescription Drug Abuse Elimination Act of 2006 -Amends the Federal Food, Drug, and Cosmetic Act to require Internet pharmacies to meet specified criteria, including: (1) providing individuals who access the pharmacy with certain information; (2) obtaining verification of a valid prescription in some circumstances; and (3) providing contact information of the individual dispensing prescription drugs on the site to each state that licenses or authorizes the person to dispense drugs. Prohibits the sale of a prescription drug, or the ownership or operation of an illegal Internet pharmacy, in violation of the requirements of this Act. Allows district courts to order Internet providers to remove access or links to sites that violate this Act.

Directs the Secretary of Health and Human Services to promulgate chain-of-custody requirements to track prescription drugs from the manufacturer through each importer, distributor, and retailer. Deems a drug misbranded if such requirements are not met.

Amends the Controlled Substances Import and Export Act to restrict the importation of a schedule II, III, or IV drug by a U.S. resident without a valid prescription to once during any 30-day period.

Requires the Secretary, acting through the Commissioner of Food and Drugs, to: (1) convene a working group to study and report on pharmaceutical counterfeiting; and (2) study the best methods to ensure that controlled substances are not diverted for unlawful use.

Requires the Secretary to conduct research and report on issues related to prescription drug abuse.

Requires the Administrator of the Substance Abuse and Mental Health Services Administration to maintain a comprehensive, national database on deaths occurring as a result of substance abuse.

What's happening now February 17, 2006

Referred to the Subcommittee on Health.

 Committees of jurisdiction 2